Dentsply Sirona is proud to underscore its commitment to being a trusted partner to clinicians worldwide through evidence-based endodontic solutions, meticulous quality standards, and a longstanding tradition of pioneering innovation.
With a heritage spanning over 150 years, Dentsply Sirona reaffirms its commitment to advancing this area of dentistry through a solid foundation for building trust. This dedication is founded on several pillars; three core pillars are evidence-based endodontics, unwavering quality, and a pioneering spirit.
Trust rooted in evidence-based endo
Dentsply Sirona’s endodontic treatment solutions are deeply rooted in extensive scientific validation. Since their development, the company’s reciprocating endodontic files have generated 1,228 published articles: 578 related to the WaveOne family and 650 covering the Reciproc family. This evidence-based approach provides clinicians with confidence in the effectiveness and reliability of their treatment solutions.
Professor Ghassan Yared, inventor of the Reciproc reciprocating file, highlighted the importance of evidence-based innovation: “Innovation in endodontics must always be supported by rigorous scientific evidence. This is the foundation of trust. The extensive research and clinical validation behind Dentsply Sirona’s solutions helps to ensure reliable outcomes and advances the standard of patient care.”
Trust built through dedication to quality
Quality underpins every stage of manufacturing at Dentsply Sirona. With facilities in Germany, Switzerland, and the USA—each with its own long-established history of manufacturing significant innovations—the company meets rigorous global standards certified by leading regulatory authorities to produce over 140 million endodontic instruments annually. These products support more than 35 million procedures each year. Demonstrating this deep commitment, over 3 million individual quality measurements are conducted each year across these sites, helping to ensure precision, reliability, and safety in every instrument produced.
Trust born from pioneering innovation
Dentsply Sirona is driven by an unwavering spirit of innovation, continually transforming endodontic practice through groundbreaking technologies and simplified clinical procedures. The company boasts numerous industry-first milestones, including being the first to launch variable tapered files, carrier-based obturators, reciprocation techniques, the off-centering concept, and heat-treated files. Uniquely positioned in the market, Dentsply Sirona is the only endodontics company to build both its own motors and consumables that integrate seamlessly.
“Trust is the cornerstone of everything we do at Dentsply Sirona,” stated Oliver Elsner, Vice President R&D Essential Dental Solutions at Dentsply Sirona. “Clinicians and patients rely on us to deliver endodontic solutions that they trust to use on their patients every day. That is why we even design our own machines to produce our endodontic instruments—this way we have total control over quality and precision.”
To learn more about how Dentsply Sirona, with its proven and long-standing track record, is a trusted partner in endodontics, visit https://www.dentsplysirona.com/trusted-endo-partner
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.
Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.
Visit dentsplysirona.com for more information about Dentsply Sirona and its products.
DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements.
In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to the different approval and registration times, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.
